Torque Bio
Blood & Organ Banks · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8 Davis Dr Ste 110, Durham, North Caroli...Website
www.torquebio.comRevenue
<$5 MillionIndustry
About Torque Bio
Torque Bio is a biotechnology start-up focused on developing innovative genetic medicines for serious kidney diseases, particularly autosomal dominant polycystic kidney disease. The company utilizes a proprietary technology platform that combines kidney-optimized AAV vectors, gene replacement, and targeted local delivery to create durable and precise therapies. With a commitment to addressing significant unmet medical needs, Torque Bio aims to transform the treatment landscape for genetic kidney diseases. Their integrated approach seeks to tackle disease biology at its source, offering hope for patients with limited treatment options.Explore more
Torque Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Torque Bio
Compare insights from companies similar to Torque Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$16.9M
51-200
Private
$175M
2020
AM
Akira MatsunoCo-Founder & President & Chief Operating Officer & Chief Financial Officer
Torque Bio Tech Stack
A closer look at the technologies used by Torque Bio
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Torque Bio
Sign Up For FreeTo access detailed company insights
Torque Bio is a biotechnology start-up focused on developing innovative genetic medicines for serious kidney diseases, particularly autosomal dominant polycystic kidney disease. The company utilizes a proprietary technology platform that combines kidney-optimized AAV vectors, gene replacement, and targeted local delivery to create durable and preci... Read More
